Related Experiment Videos
Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis
M Yaster1, J R Tobin, C Billett
1Department of Anesthesiology/Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD.
Insights
Continuous epidural analgesia effectively manages severe pain in children with sickle cell disease during vaso-occlusive crises. This method improves pain scores and oxygenation without causing sedation or respiratory depression.
Area of Science:
- Pediatric Hematology
- Pain Management
- Anesthesiology
Background:
- Sickle cell disease (SCD) frequently causes severe vaso-occlusive crises (VOCs) leading to intense pain.
- Conventional analgesic therapies, including high-dose opioids and NSAIDs, are often insufficient for severe SCD-related pain.
- Effective pain management is crucial to prevent complications and improve patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of continuous epidural analgesia in children with SCD experiencing severe VOCs.
- To determine if epidural analgesia can improve pain control in patients unresponsive to standard treatments.
- To assess the impact of epidural analgesia on oxygenation and other physiological parameters.
Main Methods:
- Retrospective observational study involving nine children with SCD experiencing 11 VOCs.
- Patients received continuous epidural analgesia with local anesthetics, alone or with fentanyl, for refractory pain.
- Outcomes measured included pain scores, oxygen saturation, and plasma lidocaine levels.
Main Results:
- Epidural analgesia provided immediate and effective pain relief (pain score 0-2) in 8 of 9 patients.
- Continuous pain control was achieved in 9 of 11 crises, with some requiring adjustments to the anesthetic regimen.
- Oxygen saturation significantly improved from 87-95% to 99-100% in 7 of 9 patients.
- No dose-related toxicity from lidocaine was observed; complications were minor and infrequent.
Conclusions:
- Continuous epidural analgesia is an effective and safe treatment for severe sickle cell vaso-occlusive crises unresponsive to conventional therapy.
- This method offers significant pain relief without causing sedation, respiratory depression, or limiting ambulation.
- Early implementation of epidural analgesia may improve oxygenation, potentially mitigating further sickling.
Objectives:
To determine whether continuous epidural analgesia could effectively decrease pain and thereby improve the management of severe vaso-occlusive crisis in children with sickle cell disease who were unresponsive to conventional analgesic therapy.
Design:
Retrospective observational study.
Setting:
A tertiary care hospital with a large pediatric sickle cell patient referral population.
Patients:
The study describes nine children in 11 painful vaso-occlusive crises, unresponsive to high-dose systemic opioids, nonsteroidal anti-inflammatory drugs, and adjunctive measures, who underwent continuous epidural analgesia to control pain.
Outcome Measures:
Subjective pain scores, arterial oxygen saturation monitoring, and plasma lidocaine levels.
Methods:
Placement of an epidural catheter for the administration of a continuous infusion of local anesthetic, alone, or in combination with fentanyl, in the management of vaso-occlusive crisis.
Results:
An initiation of epidural analgesic therapy, 8 of 9 patients reported severe pain (8 to 10 on a scale of 0 to 10, 0 = no pain, 10 = the worst pain they ever experienced). Analgesic was immediate (pain score 0 to 2) in 8 of 9 patients, and continuously effective in 9 of 11 crises. Five patients required either the addition of fentanyl or changing the local anesthetic from lidocaine to bupivacaine to maintain analgesia for 2 to 5 days. In 7 of 9 patients, oxygen saturation dramatically increased from 87 to 95% to 99 to 100% after epidural analgesia was initiated. In all patients, plasma lidocaine levels ranged from 1.1 to 4.6 mg/L and dose-related toxicity did not occur. One patient developed hypotension secondary to high sympathetic blockade (T-4), one had an inadvertent dural puncture during insertion of the catheter, one had the epidural catheter removed for fever, and one achieved analgesia only transiently. There were no other complications, and epidural analgesia was not associated with sedation, respiratory depression, or limitation of movement. All epidural catheters were cultured on removal, and colonization did not occur.
Conclusions:
Epidural analgesia with local anesthetics administered alone or in combination with fentanyl effectively and safely treats the pain of sickle cell vaso-occlusive crisis unresponsive to conventional pain management and does so without causing sedation, respiratory depression, or significant limitation on ambulation. Furthermore, early treatment of painful crisis with this technique may improve oxygenation, a critical factor in the evolution of further sickling.